Interaction between FGFR-2, STAT5, and Progesterone Receptors in Breast Cancer
Juan P. Cerliani(Experimental Medicine and Biology Institute), Claudia Lanari(Experimental Medicine and Biology Institute)
Cited by 87
Related Papers
IRE1α–XBP1 controls T cell function in ovarian cancer by regulating mitochondrial activity
|Nature|2018|408
Progestin and antiprogestin responsiveness in breast cancer is driven by the <scp>PRA</scp>/<scp>PRB</scp> ratio <i>via</i><scp>AIB</scp>1 or <scp>SMRT</scp> recruitment to the <scp><i>CCND</i></scp><i>1</i> and <scp><i>MYC</i></scp> promoters
|International Journal of Cancer|2014|39
Biological and clinical impact of imbalanced progesterone receptor isoform ratios in breast cancer
|Endocrine Related Cancer|2018|31